公司簡介

Corporate History

2025.10
IND Approval for SA1211.The First Dual-Targeting siRNA D&rug for CHB
2022.11
Awarded as The Leading Enterprise of Suzhou
2022.10
Initiated the construction of SiranBio’s R&D center
2022.09
Successfully selected as The Leading Enterprise of Suzhou Industrial Park
2022.07
Successfully finished angel round financing
2022.05
SiranBio was founded